Figures & data
Table 1 Summary of the current US Food and Drug Administration (FDA) pregnancy safety categories
Table 2 Meta-analyses of observational studies of antenatal AD use and the risk of congenital malformations
Table 3 Meta-analyses of observational studies of antenatal AD use and the risk of cardiac malformations